Skip to main content
. 2020 Sep;21(9):2501–2506. doi: 10.31557/APJCP.2020.21.9.2501

Graphic 4.

Graphic 4

There Was No Statistical Difference Regarding CD133 Immunostaining in OEDs and OSCCs Cases when Comparing the Patients' Dgenders. (Two-way ANOVA test)